Kidney Stone Disease in Urology: Bridging Medical Expulsive Therapy, Definitive Treatment, and Recurrence Prevention

Kidney stone disease is common and recurs. This narrative review follows its care through three stages, the acute episode, definitive treatment and prevention of the next stone, and includes Saudi and Gulf data. In the acute stage, ultrasonography first rests on a randomized trial and a guideline statement, although a meta-analysis found modest accuracy of point-of-care ultrasonography, and a non-steroidal anti-inflammatory drug first rests on a randomized trial, a meta-analysis that includes it and a guideline. On alpha-blockers the sources disagree: pooled analyses favor them, whereas three of four placebo-controlled trials found no significant benefit overall. For lower pole stones, complete clearance was higher with flexible ureterorenoscopy than with shock wave lithotripsy for small stones and with percutaneous nephrolithotomy than with flexible ureterorenoscopy for larger stones. In prevention, a placebo-controlled trial of hydrochlorothiazide showed no significant difference from placebo although pooled analyses showed benefit, and a behavioral program to raise fluid intake did not reduce recurrent stone events compared with guideline-concordant care. Saudi prevalence studies differ in design and range widely between regions; no Saudi randomized trial of medical expulsive therapy, treatment choice or prevention was identified among the partially screened records of a targeted search. We then assemble a stepwise approach labeled by the type of evidence behind each step; it starts after obstruction with infection, acute kidney injury and an obstructed solitary kidney, which call for urgent decompression, have been excluded (authors' expert opinion).

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-22
DOI
https://doi.org/10.5281/zenodo.24430876
Primary Topic
Kidney Stones and Urolithiasis Treatments
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Kidney Stone Disease in Urology: Bridging Medical Expulsive Therapy, Definitive Treatment, and Recurrence Prevention

Salman Mashary Alharbi, Mohammed Ibrahim Abu Hulayyil
Zenodo (CERN European Organization for Nuclear Research)
Kidney Stones and Urolithiasis Treatments
preprint

Kidney Stone Disease in Urology: Bridging Medical Expulsive Therapy, Definitive Treatment, and Recurrence Prevention

Salman Mashary Alharbi, Mohammed Ibrahim Abu Hulayyil
preprint en

Abstract

Kidney stone disease is common and recurs. This narrative review follows its care through three stages, the acute episode, definitive treatment and prevention of the next stone, and includes Saudi and Gulf data. In the acute stage, ultrasonography first rests on a randomized trial and a guideline statement, although a meta-analysis found modest accuracy of point-of-care ultrasonography, and a non-steroidal anti-inflammatory drug first rests on a randomized trial, a meta-analysis that includes it and a guideline. On alpha-blockers the sources disagree: pooled analyses favor them, whereas three of four placebo-controlled trials found no significant benefit overall. For lower pole stones, complete clearance was higher with flexible ureterorenoscopy than with shock wave lithotripsy for small stones and with percutaneous nephrolithotomy than with flexible ureterorenoscopy for larger stones. In prevention, a placebo-controlled trial of hydrochlorothiazide showed no significant difference from placebo although pooled analyses showed benefit, and a behavioral program to raise fluid intake did not reduce recurrent stone events compared with guideline-concordant care. Saudi prevalence studies differ in design and range widely between regions; no Saudi randomized trial of medical expulsive therapy, treatment choice or prevention was identified among the partially screened records of a targeted search. We then assemble a stepwise approach labeled by the type of evidence behind each step; it starts after obstruction with infection, acute kidney injury and an obstructed solitary kidney, which call for urgent decompression, have been excluded (authors' expert opinion).

Zenodo (CERN European Organization for Nuclear Research)
King Saud University (SA)
Kidney Stones and Urolithiasis Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Kidney Stone Disease in Urology: Bridging Medical Expulsive Therapy, Definitive Treatment, and Recurrence Prevention — Salman Mashary Alharbi, Mohammed Ibrahim Abu Hulayyil · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS